Análisis Argos
ENSG
ENSGCara
The Ensign Group, Inc. · Healthcare
US$ 183.14
precio al 2026-07-28
Valor justo Argos*
US$ 80–88
vs. su valor justo
108% por encima
Score Argos
31/100
LA RESPUESTA
El mercado le pide crezca 32.6% al año — más de lo que ha demostrado (6%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Las ganancias crecieron 15% el último año.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Venta significativa de insiders en el último trimestre.
VALOR1/6FUTURO3/6PASADO2/6SALUD4/6DIVIDENDO2/6
El Iris de calidad
VALOR1/6FUTURO3/6PASADO2/6SALUD4/6DIVIDENDO2/6
ValorCotiza por encima de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance fuerte, deuda controlada
DividendoRetorno al accionista moderado
Score Argos31de 100Cara
Ingresos19%
US$ 5.1 B
Margen operativo0%
8.4%
Flujo de caja libre95%
US$ 0.4 B
Deuda neta
US$ 3.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 10.7B
P/E31.1x
EV/EBITDA27.1x
FCF yield3.5%
ROIC5.5%
Margen operativo8.4%
Crecim. ingresos+18.7%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

globenewswire.com · 10 jul
ENSG INVESTIGATION ALERT: Investigation Launched into The Ensign Group, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - RGRD Law
SAN DIEGO, July 10, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of United States federal securities laws involving The Ensign Group, Inc. (NASDAQ: ENSG). If you any have information that could assist in the Ensign investigation or if you are an Ensign investor who suffered a loss and would like to learn more, you may provide your information here: https://www.rgrdlaw.com/cases-the-ensign-group-inc-investigation-ensg.html You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at info@rgrdlaw.com.
globenewswire.com · 10 jul
Ensign (NASDAQ: ENSG) Regulatory Issues Trigger Securities Fraud Investigation – Investors Notified to Contact BFA Law
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The Ensign Group, Inc. (NASDAQ:ENSG) for potential securities fraud after significant stock drops. If you invested in Ensign, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.
prnewswire.com · 9 jul
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. - ENSG
NEW YORK, July 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Ensign Group, Inc. ("Ensign Group" or the "Company") (NASDAQ: ENSG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
globenewswire.com · 9 jul
The Ensign Group (ENSG) Shares Fall Amid Activist Forensic Reports Challenging Patient Care Claims, Legal Compliance – HBSS
SAN FRANCISCO, July 09, 2026 (GLOBE NEWSWIRE) -- The Ensign Group (NASDAQ: ENSG) investors saw the price of their shares in the skilled nursing facilities (“SNFs”) provider tumble over 8% on June 8 and another 3% on June 11, 2026 after Hunterbrook Media and Muddy Waters Research, respectively, published highly critical reports questioning Ensign's business practices. In total, over $500 million of Ensign's market capitalization has been wiped out since June 7, 2026, the day before the first of the two reports.
newsfilecorp.com · 8 jul
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
New York, New York--(Newsfile Corp. - July 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Ensign securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
businesswire.com · 8 jul
THE ENSIGN GROUP, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates The Ensign Group, Inc.'s Directors and Officers for Breach of Fiduciary Duties – ENSG
NEW YORK--(BUSINESS WIRE)---- $ENSG #NASDAQ--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of The Ensign Group, Inc. (NASDAQ: ENSG) failed to manage The Ensign Group in an acceptable manner, breaching their fiduciary duties to Ensign Group, and whether Ensign Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On June 11, 2026, Muddy Waters Resear.
businesswire.com · 8 jul
ENSG INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into The Ensign Group, Inc. and Encourages Investors and Potential Witnesses to Contact Law Firm
SAN DIEGO--(BUSINESS WIRE)---- $ENSG #ENSG--Robbins Geller is investigating potential violations of the federal securities laws by Ensign.
globenewswire.com · 8 jul
$ENSG Investment Loss: Ensign Investors that Lost Money after Regulatory Issues Disclosed are Notified to Contact BFA Law about its Securities Fraud Investigation
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into The Ensign Group, Inc. (NASDAQ:ENSG) for potential securities fraud after significant stock drops. If you invested in Ensign, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ensign-class-action-lawsuit.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.